DW-532

N/A

Report date: 2022/02/23 20:00:33

NME

Base Information

Drug NameDW-532

Drug Alias NameDW-532

ClassificationOther

Mechanisms of ActionVascular endothelial growth factor receptor 2 inhibitorsMicrotubule-associated proteins inhibitorsEpidermal growth factor receptor erbB1 antagonists

TargetsMicrotubule-associated proteinsEpidermal growth factor receptor erbB1Vascular endothelial growth factor receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A